Drug & medication recalls Moderate risk

Testosterone Cypionate for Injection recalled over manufacturing violations

Recall date
January 14, 2020
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Official notice title
Sun Pharmaceutical Industries, Inc. recalls Testosterone Cypionate for Injection, 2,000 mg/10 mL (200 mg/mL), a) 1 mL Single Use vial (NDC 62756-015-40) and b) 10…
Recall number
D-0788-2020
FDA classification
Class II
Brand / firm
Sun Pharmaceutical Industries, Inc.
Sold / distributed
Product was distributed throughout the United States.

Why it was recalled

cGMP Deviations; released lots were manufactured under similar manufacturing conditions to a previously rejected OOS Lot.

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Testosterone Cypionate for Injection, 2,000 mg/10 mL (200 mg/mL), a) 1 mL Single Use vial (NDC 62756-015-40) and b) 10 mL Multiple Dose Vial (NDC 62756-016-40), Rx only, Distributed by: Sun Pharmaceuticals, Inc., Cranbury, NJ, Manufactured by: Sun Pharmaceuticals, Industries, Ltd., Gujarat, India

Get recall alerts

Free email alert whenever Sun Pharmaceutical Industries, Inc. has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: Sun Pharmaceutical Industries, Inc.